StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
AIM

AIM ImmunoTech Inc.

AIM NYSE Biological Products, (No Diagnostic Substances) EDGAR ↗
$0.26
+0.02 +10.00%

Key statistics

from XBRL data in SEC filings
Market cap
$3.84M
Revenue (TTM)
$94.0K
Net income (TTM)
-$13.3M
EPS (TTM)
$-9.26
P/E ratio
Dividend yield
Free cash flow
-$11.0M
Cash
$5.82M
Total assets
$8.59M
Gross margin
52-week range
$0.21 – $2.91

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jul 16, 2026 8-K Other events Jun 15, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Jun 11, 2026 8-K Amended charter or bylaws Jun 10, 2026 8-K Regulation FD disclosure Jun 4, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events May 21, 2026 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Regulation FD disclosure May 19, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Regulation FD disclosure May 14, 2026 8-K Unregistered sale of equity May 12, 2026 8-K Entered a material agreement; Unregistered sale of equity May 8, 2026 8-K Entered a material agreement Apr 10, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Other events Mar 6, 2026 8-K Regulation FD disclosure; Other events Feb 5, 2026 8-K Regulation FD disclosure Jan 20, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Shareholder vote results Dec 17, 2025 8-K Entered a material agreement; Took on a direct financial obligation Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 17, 2025 8-K Entered a material agreement Oct 29, 2025 8-K Regulation FD disclosure Oct 20, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Entered a material agreement; Other events Jul 31, 2025 8-K Other events Jul 28, 2025 8-K Delisting notice or listing-rule failure; Other events Jun 20, 2025 8-K Delisting notice or listing-rule failure; Amended charter or bylaws; Other events Jun 12, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Shareholder vote results May 1, 2025 8-K Delisting notice or listing-rule failure; Other events Apr 7, 2025 8-K Entered a material agreement Apr 4, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Other events Feb 28, 2025 8-K Director or officer change; Amended charter or bylaws Feb 26, 2025 8-K Other events Feb 11, 2025 8-K Other events Feb 11, 2025 8-K Other events Feb 7, 2025 8-K Other events Feb 5, 2025 8-K Director or officer change Dec 23, 2024 8-K Shareholder vote results Dec 20, 2024